Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-133778
Filing Date
2025-06-03
Accepted
2025-06-03 07:43:05
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d40174ddefa14a.htm DEFA14A 438687
2 GRAPHIC g40174g0603013907673.jpg GRAPHIC 4131
3 GRAPHIC g88500snap2.jpg GRAPHIC 4690
4 GRAPHIC g88500snap3.jpg GRAPHIC 13554
  Complete submission text file 0001193125-25-133778.txt   470930
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40925 | Film No.: 251017173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)